| Primary |
| Thrombosis Prophylaxis |
15.1% |
| Prophylaxis |
12.7% |
| Hypertension |
11.9% |
| Pulmonary Embolism |
10.1% |
| Deep Vein Thrombosis |
8.6% |
| Atrial Fibrillation |
6.1% |
| Drug Use For Unknown Indication |
5.3% |
| Pain |
5.0% |
| Anticoagulant Therapy |
3.1% |
| Analgesic Effect |
2.5% |
| Anaesthesia |
2.4% |
| Nausea |
2.4% |
| Infection Prophylaxis |
2.4% |
| Myocardial Infarction |
2.3% |
| Antibiotic Prophylaxis |
2.2% |
| Product Used For Unknown Indication |
1.7% |
| Thrombosis |
1.6% |
| Constipation |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
|
| Death |
14.4% |
| Pulmonary Embolism |
12.9% |
| Thrombocytopenia |
12.0% |
| Haemorrhage |
7.0% |
| Haemoglobin Decreased |
4.6% |
| Maternal Exposure During Pregnancy |
4.6% |
| Vomiting |
4.6% |
| Drug Exposure During Pregnancy |
4.4% |
| Tachycardia |
4.4% |
| Hepatic Function Abnormal |
3.5% |
| Heparin-induced Thrombocytopenia |
3.3% |
| Platelet Count Decreased |
3.3% |
| Renal Failure Acute |
3.1% |
| Haematoma |
2.8% |
| Wound Secretion |
2.8% |
| Pyrexia |
2.6% |
| Retroperitoneal Haematoma |
2.6% |
| Hepatic Enzyme Increased |
2.4% |
| International Normalised Ratio Increased |
2.4% |
| Liver Injury |
2.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.6% |
| Product Used For Unknown Indication |
19.4% |
| Embolism |
7.4% |
| Thrombosis Prophylaxis |
7.3% |
| Acute Coronary Syndrome |
4.8% |
| Hypertension |
4.6% |
| Prophylaxis |
4.6% |
| Pulmonary Embolism |
4.2% |
| Deep Vein Thrombosis |
3.7% |
| Acute Myocardial Infarction |
3.3% |
| Myocardial Infarction |
3.0% |
| Atrial Fibrillation |
2.6% |
| Pain |
2.3% |
| Anticoagulant Therapy |
2.2% |
| Multiple Myeloma |
1.6% |
| Coronary Artery Disease |
1.2% |
| Hiv Infection |
1.1% |
| Thrombosis |
1.1% |
| Infection Prophylaxis |
0.9% |
| Depression |
0.9% |
|
| Thrombocytopenia |
18.1% |
| Pulmonary Embolism |
10.6% |
| Toxic Epidermal Necrolysis |
5.9% |
| Vascular Pseudoaneurysm |
5.9% |
| Gastrointestinal Haemorrhage |
4.9% |
| Renal Failure Acute |
4.9% |
| White Blood Cell Count Increased |
4.7% |
| Haemoglobin Decreased |
4.4% |
| Haemorrhage |
4.1% |
| Cerebral Haemorrhage |
3.6% |
| Pneumonia |
3.6% |
| Weight Decreased |
3.6% |
| Drug Exposure During Pregnancy |
3.4% |
| International Normalised Ratio Increased |
3.4% |
| Rectal Haemorrhage |
3.4% |
| Haematoma |
3.1% |
| Haemorrhage Intracranial |
3.1% |
| Heparin-induced Thrombocytopenia |
3.1% |
| Subdural Haematoma |
3.1% |
| Tachycardia |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.1% |
| Product Used For Unknown Indication |
21.3% |
| Prophylaxis |
7.4% |
| Hypertension |
5.6% |
| Pain |
5.1% |
| Multiple Myeloma |
4.8% |
| Thrombosis Prophylaxis |
3.6% |
| Diffuse Large B-cell Lymphoma |
3.1% |
| Rheumatoid Arthritis |
2.2% |
| Non-small Cell Lung Cancer |
2.0% |
| Atrial Fibrillation |
1.8% |
| Depression |
1.7% |
| B-cell Lymphoma |
1.5% |
| Diabetes Mellitus |
1.5% |
| Constipation |
1.5% |
| Nausea |
1.4% |
| Pulmonary Embolism |
1.2% |
| Acute Coronary Syndrome |
1.2% |
| Hiv Infection |
1.0% |
| Deep Vein Thrombosis |
1.0% |
|
| Vomiting |
13.9% |
| Thrombocytopenia |
9.1% |
| Pulmonary Embolism |
8.8% |
| Sepsis |
7.0% |
| Pyrexia |
6.1% |
| Renal Failure Acute |
6.1% |
| Renal Failure |
5.2% |
| Pneumonia |
5.0% |
| Syncope |
4.3% |
| Death |
4.2% |
| Urinary Tract Infection |
4.2% |
| Weight Decreased |
3.9% |
| Neutropenia |
3.8% |
| Somnolence |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| White Blood Cell Count Increased |
2.8% |
| Deep Vein Thrombosis |
2.6% |
| Loss Of Consciousness |
2.6% |
| Ventricular Fibrillation |
2.5% |
| Dyspnoea |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
28.0% |
| Prophylaxis |
18.0% |
| Product Used For Unknown Indication |
7.9% |
| Cardiac Failure Congestive |
6.3% |
| Urinary Tract Infection |
6.3% |
| Myocardial Infarction |
5.0% |
| Pulmonary Embolism |
5.0% |
| Atrial Fibrillation |
3.3% |
| Acute Promyelocytic Leukaemia |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Atrial Flutter |
2.5% |
| Hypertension |
2.1% |
| Convulsion |
1.7% |
| Pain |
1.7% |
| Cardiovascular Event Prophylaxis |
1.3% |
| Catheterisation Cardiac |
1.3% |
| Dyslipidaemia |
1.3% |
| Cerebrovascular Accident |
0.8% |
| Coronary Arterial Stent Insertion |
0.8% |
| Dementia Alzheimer's Type |
0.8% |
|
| Retroperitoneal Haematoma |
25.0% |
| Drug Interaction |
16.7% |
| Anxiety |
6.3% |
| Oesophageal Rupture |
6.3% |
| Prescribed Overdose |
6.3% |
| Gastrointestinal Haemorrhage |
4.2% |
| Hypovolaemic Shock |
4.2% |
| Myositis |
4.2% |
| Rhabdomyolysis |
4.2% |
| Anaemia |
2.1% |
| Chromaturia |
2.1% |
| Haematoma |
2.1% |
| Haemorrhage |
2.1% |
| Haemorrhagic Diathesis |
2.1% |
| Monoparesis |
2.1% |
| Muscle Haemorrhage |
2.1% |
| Post Procedural Haemorrhage |
2.1% |
| Prothrombin Time Prolonged |
2.1% |
| Pulmonary Haemorrhage |
2.1% |
| Purpura |
2.1% |
|
